Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jan;89(1):1-11.
doi: 10.1016/j.tube.2008.07.004. Epub 2008 Sep 14.

The Mycobacterium tuberculosis MEP (2C-methyl-d-erythritol 4-phosphate) pathway as a new drug target

Affiliations
Review

The Mycobacterium tuberculosis MEP (2C-methyl-d-erythritol 4-phosphate) pathway as a new drug target

Hyungjin Eoh et al. Tuberculosis (Edinb). 2009 Jan.

Abstract

Tuberculosis (TB) is still a major public health problem, compounded by the human immunodeficiency virus (HIV)-TB co-infection and recent emergence of multidrug-resistant (MDR) and extensively drug resistant (XDR)-TB. Novel anti-TB drugs are urgently required. In this context, the 2C-methyl-d-erythritol 4-phosphate (MEP) pathway of Mycobacterium tuberculosis has drawn attention; it is one of several pathways vital for M. tuberculosis viability and the human host lacks homologous enzymes. Thus, the MEP pathway promises bacterium-specific drug targets and the potential for identification of lead compounds unencumbered by target-based toxicity. Indeed, fosmidomycin is now known to inhibit the second step in the MEP pathway. This review describes the cardinal features of the main enzymes of the MEP pathway in M. tuberculosis and how these can be manipulated in high throughput screening campaigns in the search for new anti-infectives against TB.

PubMed Disclaimer

Figures

Fig 1
Fig 1. Various isoprenoids
Examples of isoprenoid compounds. Isopentenyl diphosphate and dimethylallyl diphosphate contribute the carbon architectures. (a) Phytol, (b) β-carotene or xanthophyll, (c) menaquinone, (d) ubiquinone, and (e) prenyl phosphate.
Fig 2
Fig 2. The mevalonate pathway for IPP biosynthesis
This pathway is an important cellular metabolic pathway present in all higher eukaryotes and some eubacteria. DMAPP and IPP serve the repeating units for the biosynthesis of isoprenoids . Abbreviation: HMG-CoA, 3-hydroxy-3-methylglutaryl CoA; HMGR, HMG-CoA reductase.
Fig 3
Fig 3. The 2C-methyl-D-erythritol 4-phosphate pathway
Most eubacteria utilize this pathway for the biosynthesis of IPP and DMAPP. Abbreviations: The names of structures are in the text. DXS, 1-deoxy-D-xylulose 5-phosphate synthase; IspC, 1-deoxy-D-xylulose 5-phosphate reductoisomerase; IspD, 4-diphosphocytidyl-2C-methyl-D-erythritol synthase; IspE, 4-diphosphocytidyl-2C-methyl-D-erythritol kinase; IspF, 2C-methyl-D-erythritol 2,4-cyclodiphosphate synthase; IspG, 1-hydroxy-2-methyl-2(E)-butenyl 4-diphosphate synthase; IspH, 1-hydroxy-2-methyl-2(E)-butenyl 4-diphosphate reductase; Idi, Isopentenyl diphosphate isomerase .

References

    1. Mathema B, Kurepina NE, Bifani PJ, Kreiswirth BN. Molecular epidemiology of tuberculosis: current insights. Clinical microbiology reviews. 2006;19:658–85. - PMC - PubMed
    1. WHO report 2007. Geneva: World Health Organization (WHO/HTM/TB/2007376); 2007. Global tuberculosis control: surveillance, planning, financing.
    1. Murray CJ, Salomon JA. Modeling the impact of global tuberculosis control strategies. Proceedings of the National Academy of Sciences of the United States of America. 1998;95:13881–6. - PMC - PubMed
    1. Sutherland I. Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli. Advances in tuberculosis research Fortschritte der Tuberkuloseforschung. 1976;19:1–63. - PubMed
    1. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, Walker AT, Friedland GH. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. The New England journal of medicine. 1989;320:545–50. - PubMed

Publication types

MeSH terms

Substances